Table 2

Patients’ responses on SpA-SCQ (n = 3984)

ResponsePresent, n (%)Treatment, n (%)Limitations, n (%)
Heart disease220 (5.5)177 (4.4)85 (2.1)
Hypertension820 (20.6)743 (18.6)100 (2.5)
Lung disease159 (4.0)120 (3.0)65 (1.6)
Diabetes201 (5.0)181 (4.5)59 (1.5)
Ulcer or stomach disease421 (10.6)346 (8.7)82 (2.1)
Kidney disease120 (3.0)65 (1.6)17 (0.4)
Liver disease129 (3.2)68 (1.7)10 (0.3)
Anaemia/other blood disease283 (7.1)134 (3.4)61 (1.5)
Cancer60 (1.5)39 (1.0)15 (0.4)
Depression534 (13.4)268 (6.7)177 (4.4)
Other medical problem 1a590 (14.8)448 (11.2)278 (7.0)
Other medical problem 2a170 (4.3)112 (2.8)57 (1.4)
Other medical problem 3a60 (1.5)44 (1.1)32 (0.8)
Uveitis747 (18.8)110 (2.8)174 (4.4)
Psoriasis880 (22.1)483 (12.1)175 (4.4)
Inflammatory bowel disease288 (7.2)115 (2.9)73 (1.8)
Osteoporosis295 (7.4)203 (5.1)74 (1.9)
Fractures195 (4.9)88 (2.2)60 (1.5)
ResponsePresent, n (%)Treatment, n (%)Limitations, n (%)
Heart disease220 (5.5)177 (4.4)85 (2.1)
Hypertension820 (20.6)743 (18.6)100 (2.5)
Lung disease159 (4.0)120 (3.0)65 (1.6)
Diabetes201 (5.0)181 (4.5)59 (1.5)
Ulcer or stomach disease421 (10.6)346 (8.7)82 (2.1)
Kidney disease120 (3.0)65 (1.6)17 (0.4)
Liver disease129 (3.2)68 (1.7)10 (0.3)
Anaemia/other blood disease283 (7.1)134 (3.4)61 (1.5)
Cancer60 (1.5)39 (1.0)15 (0.4)
Depression534 (13.4)268 (6.7)177 (4.4)
Other medical problem 1a590 (14.8)448 (11.2)278 (7.0)
Other medical problem 2a170 (4.3)112 (2.8)57 (1.4)
Other medical problem 3a60 (1.5)44 (1.1)32 (0.8)
Uveitis747 (18.8)110 (2.8)174 (4.4)
Psoriasis880 (22.1)483 (12.1)175 (4.4)
Inflammatory bowel disease288 (7.2)115 (2.9)73 (1.8)
Osteoporosis295 (7.4)203 (5.1)74 (1.9)
Fractures195 (4.9)88 (2.2)60 (1.5)
a

The SCQ includes the option to fill in one to three other non-specified medical problems. SpA-SCQ: spondyloarthritis self-administered comorbidity questionnaire.

Table 2

Patients’ responses on SpA-SCQ (n = 3984)

ResponsePresent, n (%)Treatment, n (%)Limitations, n (%)
Heart disease220 (5.5)177 (4.4)85 (2.1)
Hypertension820 (20.6)743 (18.6)100 (2.5)
Lung disease159 (4.0)120 (3.0)65 (1.6)
Diabetes201 (5.0)181 (4.5)59 (1.5)
Ulcer or stomach disease421 (10.6)346 (8.7)82 (2.1)
Kidney disease120 (3.0)65 (1.6)17 (0.4)
Liver disease129 (3.2)68 (1.7)10 (0.3)
Anaemia/other blood disease283 (7.1)134 (3.4)61 (1.5)
Cancer60 (1.5)39 (1.0)15 (0.4)
Depression534 (13.4)268 (6.7)177 (4.4)
Other medical problem 1a590 (14.8)448 (11.2)278 (7.0)
Other medical problem 2a170 (4.3)112 (2.8)57 (1.4)
Other medical problem 3a60 (1.5)44 (1.1)32 (0.8)
Uveitis747 (18.8)110 (2.8)174 (4.4)
Psoriasis880 (22.1)483 (12.1)175 (4.4)
Inflammatory bowel disease288 (7.2)115 (2.9)73 (1.8)
Osteoporosis295 (7.4)203 (5.1)74 (1.9)
Fractures195 (4.9)88 (2.2)60 (1.5)
ResponsePresent, n (%)Treatment, n (%)Limitations, n (%)
Heart disease220 (5.5)177 (4.4)85 (2.1)
Hypertension820 (20.6)743 (18.6)100 (2.5)
Lung disease159 (4.0)120 (3.0)65 (1.6)
Diabetes201 (5.0)181 (4.5)59 (1.5)
Ulcer or stomach disease421 (10.6)346 (8.7)82 (2.1)
Kidney disease120 (3.0)65 (1.6)17 (0.4)
Liver disease129 (3.2)68 (1.7)10 (0.3)
Anaemia/other blood disease283 (7.1)134 (3.4)61 (1.5)
Cancer60 (1.5)39 (1.0)15 (0.4)
Depression534 (13.4)268 (6.7)177 (4.4)
Other medical problem 1a590 (14.8)448 (11.2)278 (7.0)
Other medical problem 2a170 (4.3)112 (2.8)57 (1.4)
Other medical problem 3a60 (1.5)44 (1.1)32 (0.8)
Uveitis747 (18.8)110 (2.8)174 (4.4)
Psoriasis880 (22.1)483 (12.1)175 (4.4)
Inflammatory bowel disease288 (7.2)115 (2.9)73 (1.8)
Osteoporosis295 (7.4)203 (5.1)74 (1.9)
Fractures195 (4.9)88 (2.2)60 (1.5)
a

The SCQ includes the option to fill in one to three other non-specified medical problems. SpA-SCQ: spondyloarthritis self-administered comorbidity questionnaire.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close